Total words: 4094 | 2-word phrases: 1056 | 3-word phrases: 1247 | 4-word phrases: 1302
PAGE INFO
| Title | Try to keep the title under 60 characters (11 characters)
Amsler Grid |
| Description | Try to keep the meta description between 50 - 160 characters (0 characters)
|
| Keywords | Meta keywords are not recommended anymore (0 characters)
|
| H1 | H1 tag on the page (15 characters)
The Amsler Grid |
ONE WORD PHRASES 489 Words
| # |
Keyword |
H1 |
Title |
Des |
Volume |
Position |
Suggest |
Frequency |
Density |
| 1 | the | | | | | | | 100 | 20.45% |
| 2 | of | | | | | | | 62 | 12.68% |
| 3 | to | | | | | | | 34 | 6.95% |
| 4 | a | | | | | | | 29 | 5.93% |
| 5 | in | | | | | | | 27 | 5.52% |
| 6 | amsler | | | | | | | 25 | 5.11% |
| 7 | is | | | | | | | 24 | 4.91% |
| 8 | grid | | | | | | | 23 | 4.70% |
| 9 | vision | | | | | | | 20 | 4.09% |
| 10 | and | | | | | | | 20 | 4.09% |
TWO WORD PHRASES 1056 Words
| # |
Keyword |
H1 |
Title |
Des |
Volume |
Position |
Suggest |
Frequency |
Density |
| 1 | of the | | | | | | | 23 | 2.18% |
| 2 | in the | | | | | | | 18 | 1.70% |
| 3 | amsler grid? | | | | | | | 18 | 1.70% |
| 4 | amsler grid | | | | | | | 18 | 1.70% |
| 5 | the amsler | | | | | | | 13 | 1.23% |
| 6 | on a | | | | | | | 12 | 1.14% |
| 7 | is a | | | | | | | 7 | 0.66% |
| 8 | at a | | | | | | | 6 | 0.57% |
| 9 | macular degeneration | | | | | | | 6 | 0.57% |
| 10 | of a | | | | | | | 5 | 0.47% |
| 11 | neovascular amd | | | | | | | 5 | 0.47% |
| 12 | from the | | | | | | | 5 | 0.47% |
| 13 | such a | | | | | | | 5 | 0.47% |
| 14 | that a | | | | | | | 5 | 0.47% |
| 15 | in a | | | | | | | 5 | 0.47% |
| 16 | their vision | | | | | | | 5 | 0.47% |
| 17 | patients with | | | | | | | 5 | 0.47% |
| 18 | vision defect | | | | | | | 5 | 0.47% |
| 19 | degeneration a | | | | | | | 5 | 0.47% |
| 20 | visual acuity | | | | | | | 5 | 0.47% |
THREE WORD PHRASES 1247 Words
| # |
Keyword |
H1 |
Title |
Des |
Volume |
Position |
Suggest |
Frequency |
Density |
| 1 | the amsler grid | | | | | | | 10 | 0.80% |
| 2 | the amsler grid? | | | | | | | 10 | 0.80% |
| 3 | macular degeneration a | | | | | | | 4 | 0.32% |
| 4 | any of the | | | | | | | 4 | 0.32% |
| 5 | the treatment of | | | | | | | 3 | 0.24% |
| 6 | cnv lesion size | | | | | | | 2 | 0.16% |
| 7 | earlier intervention when | | | | | | | 2 | 0.16% |
| 8 | of macular function | | | | | | | 2 | 0.16% |
| 9 | has lead to | | | | | | | 2 | 0.16% |
| 10 | tool for patients | | | | | | | 2 | 0.16% |
| 11 | for patients with | | | | | | | 2 | 0.16% |
| 12 | in the effectiveness | | | | | | | 2 | 0.16% |
| 13 | selfassessment of vision | | | | | | | 2 | 0.16% |
| 14 | and visual acuity | | | | | | | 2 | 0.16% |
| 15 | grid fails to | | | | | | | 2 | 0.16% |
| 16 | fails to detect | | | | | | | 2 | 0.16% |
| 17 | use the amsler | | | | | | | 2 | 0.16% |
| 18 | lines on a | | | | | | | 2 | 0.16% |
| 19 | amsler grid this | | | | | | | 2 | 0.16% |
| 20 | in the center | | | | | | | 2 | 0.16% |
| 21 | dot in the | | | | | | | 2 | 0.16% |
| 22 | lesion size is | | | | | | | 2 | 0.16% |
| 23 | acuity is better | | | | | | | 2 | 0.16% |
| 24 | visual acuity is | | | | | | | 2 | 0.16% |
| 25 | of the vision | | | | | | | 2 | 0.16% |
| 26 | of the two | | | | | | | 2 | 0.16% |
| 27 | of neovascular amd | | | | | | | 2 | 0.16% |
| 28 | in the treatment | | | | | | | 2 | 0.16% |
| 29 | visual acuity and | | | | | | | 2 | 0.16% |
| 30 | the effectiveness of | | | | | | | 2 | 0.16% |
FOUR WORD PHRASES 1302 Words
| # |
Keyword |
H1 |
Title |
Des |
Volume |
Position |
Suggest |
Frequency |
Density |
| 1 | dot in the center | | | | | | | 2 | 0.15% |
| 2 | the amsler grid has | | | | | | | 2 | 0.15% |
| 3 | in the treatment of | | | | | | | 2 | 0.15% |
| 4 | and visual acuity is | | | | | | | 2 | 0.15% |
| 5 | in the effectiveness of | | | | | | | 2 | 0.15% |
| 6 | the effectiveness of the | | | | | | | 2 | 0.15% |
| 7 | grid fails to detect | | | | | | | 2 | 0.15% |
| 8 | amsler grid has been | | | | | | | 2 | 0.15% |
| 9 | effectiveness of the two | | | | | | | 2 | 0.15% |
| 10 | visual acuity is better | | | | | | | 2 | 0.15% |
| 11 | tool for patients with | | | | | | | 2 | 0.15% |
| 12 | use the amsler grid | | | | | | | 2 | 0.15% |
| 13 | scotomas that are present | | | | | | | 1 | 0.08% |
| 14 | drug that is used | | | | | | | 1 | 0.08% |
| 15 | that is used in | | | | | | | 1 | 0.08% |
| 16 | is used in the | | | | | | | 1 | 0.08% |
| 17 | used in the treatment | | | | | | | 1 | 0.08% |
| 18 | of amd it has | | | | | | | 1 | 0.08% |
| 19 | been shown to be | | | | | | | 1 | 0.08% |
| 20 | the scotomas that are | | | | | | | 1 | 0.08% |
| 21 | detect approximately half of | | | | | | | 1 | 0.08% |
| 22 | newest antivegf drug that | | | | | | | 1 | 0.08% |
| 23 | shown to be as | | | | | | | 1 | 0.08% |
| 24 | to be as effective | | | | | | | 1 | 0.08% |
| 25 | be as effective as | | | | | | | 1 | 0.08% |
| 26 | as effective as the | | | | | | | 1 | 0.08% |
| 27 | effective as the other | | | | | | | 1 | 0.08% |
| 28 | as the other agents | | | | | | | 1 | 0.08% |
| 29 | the other agents but | | | | | | | 1 | 0.08% |
| 30 | other agents but has | | | | | | | 1 | 0.08% |
| 31 | agents but has a | | | | | | | 1 | 0.08% |
| 32 | but has a longer | | | | | | | 1 | 0.08% |
| 33 | antivegf drug that is | | | | | | | 1 | 0.08% |
| 34 | the amsler grid amsler | | | | | | | 1 | 0.08% |
| 35 | the newest antivegf drug | | | | | | | 1 | 0.08% |
| 36 | of lucentis and avastin | | | | | | | 1 | 0.08% |
| 37 | used off label the | | | | | | | 1 | 0.08% |
| 38 | catt study was a | | | | | | | 1 | 0.08% |
| 39 | study was a randomized | | | | | | | 1 | 0.08% |
| 40 | was a randomized controlled | | | | | | | 1 | 0.08% |
EXTERNAL LINKS
| # |
URL |
Whois |
Check |
| 1 | https://en.wikipedia.org/wiki/Marc_Amsler
| Whois | wikipedia.org |
| 2 | https://nei.nih.gov/health/maculardegen/armd_facts
| Whois | nih.gov |
| 3 | https://www.aao.org/eye-health/diseases/avastin-eylea-lucentis-difference
| Whois | aao.org |
| 4 | https://emedicine.medscape.com/article/1190818-overview
| Whois | medscape.com |
| 5 | https://www.ncbi.nlm.nih.gov/pubmed/29383980
| Whois | nih.gov |
| 6 | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3157322
| Whois | nih.gov |
| 7 | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1857645
| Whois | nih.gov |
| 8 | https://www.ncbi.nlm.nih.gov/pubmed/18426417
| Whois | nih.gov |